- Motley Fool•11 hours ago
Looking to buy biotech stocks? Here are 7 important things to know.
- Investor's Business Daily•3 days ago
Bristol-Myers Squibb and Cytomx could be working on a less potent version of Yervoy and have data as early as 2018, an analyst said Thursday.
- Business Wire•3 days ago
Incyte's Immuno-oncology and Targeted Therapy Clinical Portfolio to be Featured in More than 15 Abstracts at the 2017 ASCO Annual Meeting
Incyte Corporation announces that more than 15 abstracts highlighting its research and development portfolio in immuno-oncology and targeted therapies will be presented at the upcoming 2017 American Society of Clinical Oncology annual meeting in Chicago, Illinois from June 2-6, 2017.
INCY : Summary for Incyte Corporation - Yahoo Finance
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||120.45 x 100|
|Ask||123.05 x 100|
|Day's Range||122.51 - 125.35|
|52 Week Range||68.03 - 153.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||227.80|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|